Geneos Wealth Management’s ModivCare MODV Stock Holding History

Geneos Wealth Management’s Portfolio MODV Stock Details MODV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-172	Closed	-$11K	–	2514
2019 Q1	$11K	Hold	172	–	–	﹤0.01%	1810
2018 Q4	$10K	Sell	172 -90	-34%	-$5.96K	﹤0.01%	1786
2018 Q3	$17K	Hold	262	–	–	﹤0.01%	1654
2018 Q2	$20K	Hold	262	–	–	﹤0.01%	1446
2018 Q1	$18K	Hold	262	–	–	﹤0.01%	1435
2017 Q4	$15K	Hold	262	–	–	﹤0.01%	1490
2017 Q3	$14K	Hold	262	–	–	﹤0.01%	1460
2017 Q2	$13K	Hold	262	–	–	﹤0.01%	1435
2017 Q1	$11K	Hold	262	–	–	﹤0.01%	1451
2016 Q4	$9K	Hold	262	–	–	﹤0.01%	1466
2016 Q3	$12K	Hold	262	–	–	﹤0.01%	1310
2016 Q2	$11K	Hold	262	–	–	﹤0.01%	1295
2016 Q1	$13K	Buy	+262	New	+$12.3K	﹤0.01%	1225

Other funds holding MODV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

NPIC

Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Geneos Wealth Management's MODV Position: Q2 2019 in Review

Geneos Wealth Management sold out of ModivCare (MODV) in Q2 2019, closing a stake of 172 shares — an estimated $11K sold.

Geneos Wealth Management first reported a position in MODV in Q1 2016 and held it in 13 quarters. The position peaked at $20K in Q2 2018. 158 funds tracked by Wall St. Rank hold MODV as of Q2 2019.

Geneos Wealth Management reported no remaining ModivCare position as of Q2 2019 after selling out during the quarter.
Geneos Wealth Management sold 172 ModivCare shares in Q2 2019, an estimated $11K.
Geneos Wealth Management first reported a position in ModivCare in Q1 2016 and held it in 13 quarters.
Geneos Wealth Management's ModivCare position peaked at $20K in Q2 2018.
158 funds tracked by Wall St. Rank held ModivCare as of Q2 2019.

Based on Geneos Wealth Management's 13F filing for Q2 2019, filed 7 Sep 2021.